Literature DB >> 24657120

Synonymous ABCA3 variants do not increase risk for neonatal respiratory distress syndrome.

Jennifer A Wambach1, Daniel J Wegner2, Hillary B Heins2, Todd E Druley3, Robi D Mitra4, Aaron Hamvas2, F Sessions Cole2.   

Abstract

OBJECTIVE: To determine whether synonymous variants in the adenosine triphosphate-binding cassette A3 transporter (ABCA3) gene increase the risk for neonatal respiratory distress syndrome (RDS) in term and late preterm infants of European and African descent. STUDY
DESIGN: Using next-generation pooled sequencing of race-stratified DNA samples from infants of European and African descent at ≥34 weeks gestation with and without RDS (n = 503), we scanned all exons of ABCA3, validated each synonymous variant with an independent genotyping platform, and evaluated race-stratified disease risk associated with common synonymous variants and collapsed frequencies of rare synonymous variants.
RESULTS: The synonymous ABCA3 variant frequency spectrum differs between infants of European descent and those of African descent. Using in silico prediction programs and statistical strategies, we found no potentially disruptive synonymous ABCA3 variants or evidence of selection pressure. Individual common synonymous variants and collapsed frequencies of rare synonymous variants did not increase disease risk in term and late-preterm infants of European or African descent.
CONCLUSION: In contrast to rare, nonsynonymous ABCA3 mutations, synonymous ABCA3 variants do not increase the risk for neonatal RDS among term and late-preterm infants of European or African descent.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24657120      PMCID: PMC4035386          DOI: 10.1016/j.jpeds.2014.02.021

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

Review 1.  Hearing silence: non-neutral evolution at synonymous sites in mammals.

Authors:  J V Chamary; Joanna L Parmley; Laurence D Hurst
Journal:  Nat Rev Genet       Date:  2006-02       Impact factor: 53.242

2.  Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Kazumitsu Ueda; Nobuya Inagaki
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

3.  Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.

Authors:  Frank Brasch; Sven Schimanski; Christian Mühlfeld; Stefan Barlage; Thomas Langmann; Charalampos Aslanidis; Alfred Boettcher; Ashraf Dada; Horst Schroten; Eva Mildenberger; Eric Prueter; Manfred Ballmann; Matthias Ochs; Georg Johnen; Matthias Griese; Gerd Schmitz
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

4.  ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells.

Authors:  Yoshihiro Matsumura; Hiromichi Sakai; Mayumi Sasaki; Nobuhiro Ban; Nobuya Inagaki
Journal:  FEBS Lett       Date:  2007-06-06       Impact factor: 4.124

Review 5.  ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease.

Authors:  Janine E Bullard; Susan E Wert; Lawrence M Nogee
Journal:  Semin Perinatol       Date:  2006-12       Impact factor: 3.300

6.  A "silent" polymorphism in the MDR1 gene changes substrate specificity.

Authors:  Chava Kimchi-Sarfaty; Jung Mi Oh; In-Wha Kim; Zuben E Sauna; Anna Maria Calcagno; Suresh V Ambudkar; Michael M Gottesman
Journal:  Science       Date:  2006-12-21       Impact factor: 47.728

7.  ABCA3 as a lipid transporter in pulmonary surfactant biogenesis.

Authors:  Nobuhiro Ban; Yoshihiro Matsumura; Hiromichi Sakai; Yasukazu Takanezawa; Mayumi Sasaki; Hiroyuki Arai; Nobuya Inagaki
Journal:  J Biol Chem       Date:  2007-01-30       Impact factor: 5.157

8.  Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Nobuya Inagaki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

Review 9.  Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.

Authors:  Zuben E Sauna; Chava Kimchi-Sarfaty; Suresh V Ambudkar; Michael M Gottesman
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

10.  Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else?

Authors:  Jean-Vincent Chamary; Laurence D Hurst
Journal:  Trends Genet       Date:  2005-05       Impact factor: 11.639

View more
  4 in total

1.  Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Lyudmila N Kaliberova; Sergey A Kaliberov; David T Curiel; Frances V White; Aaron Hamvas; Brian P Hackett; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

2.  Population-based frequency of surfactant dysfunction mutations in a native Chinese cohort.

Authors:  Yu-Jun Chen; Jennifer Anne Wambach; Kelcey DePass; Daniel James Wegner; Shao-Ke Chen; Qun-Yuan Zhang; Hillary Heins; Francis Sessions Cole; Aaron Hamvas
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

3.  A novel synonymous ABCA3 variant identified in a Chinese family with lethal neonatal respiratory failure.

Authors:  Weifeng Zhang; Zhiyong Liu; Yiming Lin; Ruiquan Wang; Jinglin Xu; Ying He; Fengfeng Zhang; Lianqiang Wu; Dongmei Chen
Journal:  BMC Med Genomics       Date:  2021-10-29       Impact factor: 3.063

4.  Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter.

Authors:  Zoltán N Oltvai; Eric A Smith; Katie Wiens; Lawrence M Nogee; Mark Luquette; Andrew C Nelson; Kathryn A Wikenheiser-Brokamp
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.